Introduction {#Sec1}
============

Acute gastroenteritis is the leading cause of morbidity worldwide especially among children under five years old and elderly population (Patel and Glass [@CR69]). This is associated with important medical and healthcare costs. Foodborne viruses infect humans via gastrointestinal tracts and are excreted through feces, in a process known as fecal--oral route (Lee *et al.*[@CR51]). Among these foodborne agents, norovirus (NoV), rotavirus (RV), adenovirus (AdV) and astrovirus (AsV) are considered the most important aetiological agents of acute non-bacterial gastroenteritis, transmitted by contaminated food and water (Phan *et al.*[@CR71]; Amaral *et al.*[@CR5]). Although nowadays the knowledge about viral foodborne diseases is extensive, the study of fecal--oral route is relatively recent. The first documented outbreak associated with food was in 1914, and the causative agent was recognized as poliovirus and transmitted through raw milk (Jubb [@CR38]). This viral pathogen was later classified as a member of *Picornaviridae* family (Fenner [@CR25]).

History and Taxonomy {#Sec2}
====================

The picornavirus term (*pico:* small*; rna:* ribonucleic acid*)* was first introduced in 1963. This viral family includes virus of small size with single-stranded RNA (ssRNA) as genetic material and contains many important human and animal pathogens (Melnick *et al.*[@CR59]; Melnick [@CR58]). The family *Picornaviridae* belongs to the order of *Picornavirales* and consists in 94 species grouped into 40 recognized genera (Fig. [1](#Fig1){ref-type="fig"}) (Adams *et al.*[@CR1]; King *et al.*[@CR43]).Fig. 1Phylogenetic tree, based on the P1 protein gene, showing the relationships among members of the family *Picornaviridae.* The maximum likelihood tree was constructed using MEGA 7.6. GenBank accession numbers of the reference strains used are detailed in the tree.

Within all of these recognized genera, this review is focused on *Kobuvirus.* It was classified as a new genus in 1999 (King *et al.*[@CR42]). The name comes from the Japanese word 'kobu' that means bump, and it refers to the characteristic morphology of the virion that appears bumpy at the electron microscope (Yamashita *et al.*[@CR101]). The first three official candidates of *Kobuvirus* were *Aichi virus*, *Bovine kobuvirus* and *Porcine kobuvirus* which were described on the basis of the host in which the viruses were detected.

Nowadays, the genus *Kobuvirus* consists in six recently renamed species: *Aichivirus A* (formerly *Aichi virus*), *Aichivirus B* (*Bovine kobuvirus*), *Aichivirus C* (*Porcine kobuviru*), *Aichivirus D* (kagovirus from black cattles), *Aichivirus E* (*Rabbit picornavirus*) *and Aichivirus F* (*Bat kobuvirus*) (Adams *et al.*[@CR1]; Zell [@CR105]). There are three tentative kobuviruses including caprine kobuvirus, Norway rat kobuvirus and a recovered viral genome from metagenomic sequences obtained from bat stool in Texas (USA) (Zell [@CR105]).

*Aichivirus A* is divided in six types: human Aichi virus (AiV) (Yamashita *et al.*[@CR98]), canine kobuvirus (Kapoor *et al.*[@CR40]; Barros *et al.*[@CR8]), murine kobuvirus (Phan *et al.*[@CR71]), Kathmandu sewage kobuvirus (Ng *et al.*[@CR60]), roller kobuvirus (Pankovics *et al.*[@CR68]) and feline kobuvirus (Chung *et al.*[@CR18]). The other species also display a certain degree of variability, 3 types having been described in *Aichivirus B*, and 2 types in the species *Aichivirus C*, *Aichivirus D* and *Aichivirus F*. Finally, three genotypes (Fig. [2](#Fig2){ref-type="fig"}) have been described within human Aichi virus (named A to C) (Ambert-Balay *et al.*[@CR6]).Fig. 2Phylogenetic tree, based on the P1 protein gene, showing the relationships among different genotypes of human AiV. The maximum likelihood tree was constructed using MEGA 7.6. GenBank accession numbers of the reference strains used are detailed in the tree.

AiV was first recognized and isolated in BSC-1 (kidney of normal adult African green monkey) cells in 1989 during the study of a gastroenteritis outbreak associated with oyster consumption in Japan (Yamashita *et al.*[@CR98], [@CR100]). Some years later, in 1998, the complete genome sequence of AiV (GenBank accession no. AB040749) was described and classified as a novel picornavirus, at the Aichi Prefectural Institute of Public Health, in Japan (Yamashita *et al.*[@CR102]). Outside Asia, the first detections of AiV in clinical specimens were reported in Europe (Germany) and South America (Brazil) (Oh *et al.*[@CR63]).

Physical Characteristics and Stability {#Sec3}
======================================

AiV is a small non-enveloped virus with icosahedral morphology. The virions show a rough surface with around 30 nm in diameter at the electron microscopy. The capsid reveals some surface depressions like "canyon" which form the site of receptor binding in many picornaviruses (Tuthill *et al.*[@CR92]; Dang *et al.*[@CR22]; Wang *et al.*[@CR95]). *In vitro*, AiV shows stability in acid conditions as low as pH 2 and is resistant to conventional methods of inactivation, including alcohols, heat, chlorine, high hydrostatic pressure, chloroform, non-ionic detergents and ether (Yamashita *et al.*[@CR100]; Cromeans *et al.*[@CR20]). Even more, AiV retained infectivity after 21 days at 4 °C in Cranberry juice and Cranberry juice cocktail (pH 3.0) (Sewlikar and D'Souza [@CR88]).

Genomic Organization {#Sec4}
====================

AiV has a ssRNA with positive sense (8280 nucleotides), composed by a 5′ untranslated region (UTR) of about 744 nucleotides with an internal ribosomal entry site (IRES) that allows direct translation of the polyprotein and a viral genomic protein (VPg) instead of a methylated nucleotide cap structure; an open reading frame (ORF) followed by 237 nucleotides of a 3′ UTR region and a poly (A) tail (Fig. [3](#Fig3){ref-type="fig"}). The ORF is about 7.3 kb and encodes a polyprotein precursor of 2432 amino acids with a non-structural leader (L) protein at the N-terminus, followed by viral capsid proteins P1 (VP0, VP3 and VP1) and, non-structural proteins P2 (2A, 2B and 2C) and P3 (3A, 3B, 3C and 3D) that control the replication of AiV in the infected cells (Sabin *et al.*[@CR84]; Zhu *et al.*[@CR106]).Fig. 3Schematic of the monopartite, linear, ssRNA (+) genome of AiV.

Capsid proteins adopt an eight-stranded antiparallel beta barrel configuration with a pseudo *T *= 3 symmetry (where *T* is the triangulation number), where VP0 and VP3 alternate about the two- and three-fold axes and VP1 surrounds the five-fold axes (Zhu *et al.*[@CR106]). N-termini of the major capsid proteins are located inside of the capsid, and C-termini are at the virion surface. The three capsid proteins were described with weights of 42, 30 and 22 kDa (Yamashita *et al.*[@CR100]).

VP0 capsid protein remains in the mature particles of AiV, in contrast with other picornaviruses. Also, the non-structural protein 2A and L protein have not shown protease or autocatalytic motifs as are detected in other picornaviruses and their functions remain unclear (Yamashita *et al.*[@CR100]; Buesa and Rodriguez-Díaz [@CR13]). On the other hand, the 2A protein contains conserved motifs that are charateistic of the H-rev107 family, which are involved in the cellular proliferation (Hughes and Stanway [@CR33]). With regard to the other non-structural proteins, 2C, 3C and 3D regions are well aligned with the corresponding sequences of other picornavirus as *Aphthovirus, Cardiovirus* and *Parechovirus.* The 3B protein (VPg) of AiV is longer than other viruses of the same family, the 3C is the protease with conserved motifs characteristic of all picornaviruses, and the 3D region encodes the RNA-dependent RNA polymerase (RdRp) needed for viral replication (Yamashita and Sakae [@CR97]). Furthermore, a complex formed with 2B, 2BC, 2C, 3A, and 3AB proteins, Golgi apparatus protein ACBD3 and phosphatidylinositol 4-kinase IIIβ (PI4KB) at viral RNA replication sites, enhancing PI4KB-dependent phosphatidylinositol 4-phosphate (PI4P) production, is crucial for AiV replication (Klima *et al.*[@CR49]; McPhail *et al.*[@CR57]; Ishikawa-Sasaki *et al.*[@CR35]).

Viral Replication {#Sec5}
=================

As other *Picornaviridae* members, AiV enter their host cells by receptor-mediated endocytosis (Fig. [4](#Fig4){ref-type="fig"}). After adsorption, the virus penetrates the cell through little known mechanisms that followed the stripping of virions and the release of viral RNA into the cytoplasm. Using ribosomes and other cellular proteins, the viral RNA (which is already mRNA), forms polyribosomes for the direct synthesis of a polyprotein.Fig. 4Schematic of the AiV life cycle.

The polyprotein is co- and post-translationally processed into the L protein, capsid proteins, mature nonstructural proteins and stable intermediates. These proteins modify the cellular environment and promote synthesis of RNA (−) required for the complement RNA (+). When the protein combination increases, also increases the number of RNA (+) in the replicative complex that will be encapsidated after joining VPg (Belov [@CR9]; van der Schaar *et al.*[@CR93]).

As a preliminary step in the assembly, one of the cover precursors (P1) is cut by viral proteinases to form a 5S subunit (immature promoter) composed of three protein aggregates (VP0, VP3 and VP1). The 5S subunit forms pentamers, 12 of which are required to form the 60 protein subunits of the capsid.

Once the maturation process has finished, the complete viral particles has 60 copies of each capsid protein, one copy of the RNA (+) genome and one copy of VPg; these often form crystals in the cytoplasm and are finally expelled to the outside by the lysis of the infected cell (Zell [@CR105]).

Molecular Characterization and Distribution {#Sec6}
===========================================

Typing VP1 sequence is a suitable method for picornavirus classification (Oberste*et al.*[@CR62]), but 3CD junction region has been also used for that purpose in AiV (Yamashita*et al.*[@CR101]; Pham*et al.*[@CR70]). A good correlation between both classifications has been reported for AiV genotypes (Ambert-Balay*et al.*[@CR6]).

The first genetic differentiation of AiV genotypes was made by Yamashita *et al.* ([@CR101]). In that study the genetic relation among 17 AiV isolates was predicted by the comparison of 519 bases at the putative junction between the C terminus of 3C and the N terminus of 3D, and two groups were proposed: Group 1 or genotype A and group 2 or genotype B. Since then, 3 distinct genotype categories A, B and C were described (Ambert-Balay *et al.*[@CR6]; Kitajima and Gerba [@CR44]). Furthermore, several studies suggest some geographical distribution of AiV genotypes (Fig. [5](#Fig5){ref-type="fig"}).Fig. 5Worldwide distribution of human AiV genotypes. Data from AiV related gastroenteritis outbreaks and environmental samples.

Among human population, the presence of genotype A has essentially been reported in Asian countries. Thus, AiV A was detected in samples connected with 12 out of 37 gastroenteritis outbreaks in Japan (Yamashita *et al.*[@CR101]), most of them associated with oyster consumption, showing prevalences up to 81% (Table [1](#Tab1){ref-type="table"}). In addition, AiV A was detected in stool samples from travelers with diarrhea returning from India, Nepal, Thailand, Indonesia, Singapore and Vietnam, reaching percentage values of almost 100% of genotyped samples (Yamashita and Sakae [@CR97]). Further investigations also reported the same genotype in fecal samples negative for RV, AdV, NoV, Sapovirus and AsV from patients with acute gastroenteritis from Vietnam, Thailand and Bangladesh (Pham *et al.*[@CR70]).Table 1Features of the gastroenteritis outbreaks linked to AiV.CountryOutbreakYearSourcePositive rate (%)^a^GenotypeReferencesJapan11987Oysters55.0AYamashita *et al.* ([@CR101])21988Oysters71.4A3Oysters81.8A41989Oysters80.9A5School meal64.3A61990Oysters50.0B7Oysters54.5A81991Oysters50.0A91994Oysters14.3A101997Oysters62.5A111998Oysters50.0A12Oysters33.0AGermany12006NS^b^NSAOh *et al.* ([@CR63])France12006Oysters50.0AAmbert-Balay *et al.* ([@CR6])22006Oysters50.0A3Oysters17.0A42007Oysters100.0A5Oysters33.0A62007Seafood^c^6.0A^a^Numbers of fecal specimens positive/Numbers tested.^b^NS, not specified.^c^Shellfish species not specified.

In Europe the presence of AiV A was reported for the first time in Germany, from stool samples of patients involved in a gastroenteritis outbreak (Oh *et al.*[@CR63]). Afterwards the same genotype was found in France, in samples from children and adults involved in gastroenteritis outbreaks and hospitalized for acute illness (Ambert-Balay *et al.*[@CR6]), in Finland from children under 5 years with gastroenteritis (Kaikkonen *et al.*[@CR39]) and in a Hungarian sample from a 3 years old girl (Reuter *et al.*[@CR78]). AiV A was also reported in elderly patients suffering from diarrhea, who were negative for AdV, RV, and calicivirus in Sweden (Jonsson *et al.*[@CR37]) in Italy (Bergallo *et al.*[@CR10]) and among different age groups from outpatients in Spain (Rivadulla *et al.*[@CR107]). AiV A was also reported in Africa. It was detected in stool samples from inpatient and outpatient children collected in Monastir, Tunisia (Sdiri-Loulizi *et al.*[@CR86]) and, more recently, in young children with watery diarrhea in Ethiopia (Aiemjoy *et al.*[@CR2]).

AiV B was described at the same time as AiV A in samples from Japan but with less prevalence (about 16% of samples were genotyped as B) (Yamashita *et al.*[@CR101]). However, places like China, Pakistan, Bangladesh or Malaysia has been reported AiV B from patients with gastroenteritis, in higher percentages than AiV A (reaching percentages of up 100%) (Pham *et al.*[@CR70]; Yang *et al.*[@CR104]; Li *et al.*[@CR53]). On the other hand, in South Korea genotype prevalence is not clearly detected, since both genotypes were detected equally in stool samples from teenagers and adults (Han *et al.*[@CR28]). In other places as Thailand, alternance of AiV A and AiV B as predominant genotypes along the time was observed (Yamashita *et al.*[@CR101]; Saikruang *et al.*[@CR85]; Chuchaona *et al.*[@CR17]). In Europe, AiV B was also reported. In Finland and Spain AiV B was detected, but at lower prevalence than AiV A (Kaikkonen *et al.*[@CR39]; Rivadulla *et al.*[@CR107]). In Germany a genotype drift was detected, and AiV B seems to be more prevalent than in previous surveys (Drexler *et al.*[@CR24]). AiV B was detected in stool samples from Brazilian children suffering diarrhea (Oh *et al.*[@CR63]), and in North American children between 15 days and 5 years of age with symptoms of acute gastroenteritis (Chhabra *et al.*[@CR16]). In Africa, AiV B was detected from one outpatient children in Nigeria (Japhet *et al.*[@CR36]).

Only one survey reported AiV C from a stool sample of a child, hospitalized for gastroenteritis in France after a trip to Mali (Ambert-Balay [@CR6]; Reuter *et al.*[@CR79]). Further studies are needed to clarify the real impact of this genotype in human health.

Some investigations of *in vivo* evolution, based upon nt/aa changes through the complete genome, have been performed for porcine kobuvirus suggesting good adaptation of the virus-host relationship (Reuter *et al.*[@CR79]). Such research have not been carried out for human AiV yet, but it would be very helpful to understand the virus-species and host-species spectrums.

Laboratory Diagnosis {#Sec7}
====================

Detection Methods {#Sec8}
-----------------

Since AiV was discovered, various methods have been used to identify it (Table [2](#Tab2){ref-type="table"}). Under electron microscopy, the viral particles have a distinct ultrastructure than other gastroenteritis pathogens as Sapovirus (SaV) or NoV, but there are not easy to distinguish from other small round viruses and could be wrongly be classified as an AsV (Yamashita *et al.*[@CR99]). Although AiV have not shown cytopathic effect (CPE) in human cell lines as HeLa (Human cervix epitheloid carcinoma), HEL (Human Erythroleukemia Cell Line), RD (Human rhabdomyosarcoma Cell Line) cells or in newborn mice, AiV cause CPE on BSC-1 and Vero (both obtained from kidney of African green monkeys) cells (Yamashita *et al.*[@CR99]). An enzyme-linked immunosorbent assay (ELISA) was also developed for the detection of AiV antigens in clinical samples using monoclonal antibodies (Yamashita *et al.*[@CR99]).Table 2Laboratory diagnostic methods for AiV.Laboratory diagnostic methodAdvantagesDisadvantagesElectron microscopyVisualization of viral particlesLabour and tedious. Useless for environmental samplesCell cultureVariety of sensitive cell lines. Determination of infectivity. Quantitative (TCID~50~)Labour and tedious. Effect of inhibitors/contaminantsELISA^a^Sensitivity. EspecificityEffect of inhibitors. Limited use for environmental samplesLAMP^b^Sensitivity. Especificity. Rapidity. Isothermal conditionsDetection of infective and non-infective particles. Effect of inhibitorsRT-PCR^c^Sensitivity. Especificity. RapidityDetection of infective and non-infective particles. Effect of inhibitorsRT-nested PCRSensitivity. Especificity. Valid for genotyping coupled with sequencingDetection of infective and non-infective particles. Effect of inhibitorsRT-qPCR^d^Sensitivity. Especificity. Rapidity. QuantificationDetection of infective and non-infective particles. Need of standard for quantification. ExpensiveDigital RT-PCRSensitivity. Especificity. Rapidity. Absolute quantificationDetection of infective and non-infective particles. Hard optimization. ExpensivePyrosequencingSensitivity. Universal detectionComplex sample processing and bioinformatic analysis. Expensive^a^ELISA, enzyme-linked immunosorbent assay.^b^LAMP, loop-mediated isothermal amplification.^c^RT-PCR, reverse transcription-polymerase chain reaction.^d^RT-qPCR, real time quantitative RT-PCR.

Reverse transcription-polymerase chain reaction (RT-PCR) is a widely employed method for AiV research. It is a sensitive method applicable for further genetic analysis as genotyping (Yamashita *et al.*[@CR101]). As mentioned before, the 3CD junction region and VP1 region are suitable for differentiation of AiV genotypes. Nonetheless, no phylogenetic evidence of recombination has been reported between AiV genotypes A and B, suggesting that both genotyping methods are reliable (Lukashev *et al.*[@CR56]; Kitajima and Gerba [@CR44]). Nested PCR targeting the 3C, VP1, and VP3 regions, as well as multiplex semi-nested PCR on VP0-VP3 region were also developed for genotyping (Oh *et al.*[@CR63]; Lodder *et al.*[@CR54]).

Recently, Oshiki *et al.* ([@CR65]) reported a high-throughput detection and genotyping tool for RNA virus, like AiV, using a microfluidic device and next-generation sequencer. In this study the investigators reported detection limits ranging from 10^0^ to 10^3^ copies/μL in cDNA sample, corresponding to 10^1^--10^4^ copies/mL-sewage, 10^5^--10^8^ copies/g-human feces, and 10^2^--10^5^ copies/g-digestive tissues of oyster. Simultaneous detection and genotyping techniques are powerful tools for source tracking of human pathogenic viruses.

A loop-mediated isothermal amplification procedure was developed by Lee and coworkers (Lee *et al.*[@CR52]), for rapid and specific detection of AiV from water samples. The whole protocol can be performed in 2--8 h showing equivalent AiV detection than conventional PCR.

Quantification Methods {#Sec9}
----------------------

Although conventional culture methods like 50% Tissue culture Infective Dose (TCID~50~) are used to quantify AiV, methodological advances in molecular biology lead to the development of better technologies. Reverse transcription- quantitative PCR (RT-qPCR) is nowadays the most employed method for AiV detection and quantification. The highly conserved 5′-UTR sequence is a common RT-qPCR target for picornavirus detection (Drexler *et al.*[@CR24]; Nielsen *et al.*[@CR61]). However, a RT-qPCR that amplifies the VP0 region, and could quantify and differentiate between genotypes A and B, was developed for determination of viral RNA load in clinical and environmental samples (Kitajima *et al.*[@CR46]). This RT-qPCR consists in two amplifications: one that uses a universal primer pair that could amplify both genotypes and a universal probe to detect AiV. The second one uses the same primer pair but two different genotype-specific probes. Both methods, VP0 qPCR and 5′-UTR qPCR showed similar efficiency for AiV detection, with the advantage that VP0 qPCR is able to quantify and also differentiate the AiV genotypes.

Although, these techniques have been helpful to clarify the transmission sources of AiV among population, during the recent years, new detection technologies have been developed. Digital RT-PCR (RT-dPCR) is a precise endpoint-sensitive absolute quantification approach, capable of determine the number of target copies without a standard curve. As an example, AiV and eighteen enteric viruses more were targeted with this method and compared with RT-qPCR (Coudray-Meunier *et al.*[@CR19]), the conclusions were that the limit of AiV detection for RT-dPCR assay was lower (7.8 × 10^2^ genome copies/μL) than the limit of detection obtained with conventional RT-qPCR (1.0 × 10^3^ genome copies/μL). This new technology presents many advantages and possibilities for detection of enteric pathogens in environmental and clinical samples. The RT-dPCR divides each reaction mix across thousands of individual PCR reactions, making this method more tolerant to inhibitory substances and also reducing the difficulty of virus quantification (Pinheiro *et al.*[@CR72]; Rački *et al.*[@CR77]).

Clinical and Epidemiological Observations {#Sec10}
=========================================

Symptoms and Importance of Disease {#Sec11}
----------------------------------

Gastrointestinal illness is commonly associated with symptoms produced by enteric viruses but usually masked for the presence of other pathogens (Yamashita and Sakae [@CR97]). AiV replicates in the gastrointestinal tract, resulting usually in symptomless infections. Diarrhea, abdominal pain, nausea, vomiting and fever are the clinical symptoms but pathogenesis of AiV releases more in subclinical infections than in clinically manifest diseases (Yamashita *et al.*[@CR98], [@CR102]). These subclinical infections do not need healthcare attention and underestimate the real impact of AiV in human health (Bergallo *et al.*[@CR10]).

Nowadays, the clinical role of AiV as gastrointestinal pathogen stills unclear. Some surveys support the idea that AiV produce the outbreaks in coinfection with other viruses, because its frequent codetection with other enteric pathogens. This idea is also supported for the low incidence rates (0.9%--4.1%) of AiV outbreaks (Kaikkonen *et al.*[@CR39]; Jonsson *et al.*[@CR37]; Nielsen *et al.*[@CR61]). However, other studies showed high proportion of AiV monoinfections (Yang *et al.*[@CR104]; Rivadulla *et al.*[@CR107]), supporting the hypothesis that it is a gastrointestinal pathogen virulent enough to cause the need of medical are and hospitalization (Drexler *et al.*[@CR24]; Chhabra *et al.*[@CR16]).

When the illness appears is generally mild, lasting 48--72 h as is usual in this kind of enteric viruses (Carter [@CR15]). AiV replicate and destroy the enterocyte layer covering the upper third of intestinal villi. That destruction of functional and mature cells interrupts the reabsorption of water and diarrhea ensues. As a response, villi get retracted and the absorption surface area decreases. Meanwhile, crypt cells undergo rapid division to repopulate the villi with immature cells resistant to the infection, but the younger cells can not replace the function of those that were infected because they require time to mature and diarrhea appears (Carter [@CR15]). AiV is a cause of chronic infection in X-linked agammaglobulinemia and its prevalence in stool samples from patients with human immunodeficiency virus is high, indicating an opportunistic behavior in people with underlaying T cell defects (Oude Munnink *et al.*[@CR67]; Portes *et al.*[@CR75]; Bucciol *et al.*[@CR12]).

The case of a Hungarian 3 years old girl is remarkable. The patient, positive for AiV (genotype A), showed rhinitis, purulent conjunctivitis and diarrhea and, after the first sampling day, she developed bronchopneumonia and fever with an elevated erythrocyte sedimentation rate (Reuter *et al.*[@CR78]). In addition, the virus has also been associated with lower respiratory tract disease in Japan (Yamashita *et al.*[@CR99]). These cases indicate the potential of AiV to cause extraintestinal disorders.

Immunity {#Sec12}
--------

Human AiV consists in one single serotype. Virological surveys suggest that AiV is responsible for a low percentage (0.5%--1.8%) of gastroenteritis sporadic cases (Kitajima and Gerba [@CR44]; Alcalá *et al.*[@CR4]). However, high prevalence of antibodies against AiV (anti-AiV) was observed over the world.

The first seroprevalence study was carried out in Japan. In that survey the highest rate of anti-AiV was observed in adults of about 35 years old (Yamashita *et al.*[@CR99]). Since then, several studies detected high levels of AiV seroprevalence worldwide and its correlation with the age of patients.

Several studies reported high percentages of AiV seroprevalence in Europe. In Germany, the percentages rise from 51%, in children aged from 0 to 3 years, to almost 100%, in patients \> 40 years old (Oh *et al.*[@CR63]). Similar results were achieved in France, where these percentages increased steadily from 25% in infants between 7 months to 9 years old to 85%--90% in patients older than 40 years, with no significant variations among age groups after age 40 (Goyer *et al.*[@CR27]). In Spain, a significant increase of anti-AiV was observed up to the age of 30 years old, with the absence of a significant increase after that age (Ribes *et al.*[@CR80]). Also, in the same study the percentage of anti-AiV observed was 100% in individuals over the age of 40 years old.

Serological studies carried out in Tunisia, revealed also a high prevalence of anti-AiV in humans of different age groups (Sdiri-Loulizi *et al.*[@CR86]). As in the previous studies, the presence of anti-AiV throughout population increased with age raising from 68.8%, in patients between 6 months and 10 years old, to 100% in elderly patients between 71 and 89 years old. This same study showed no significant variations in seroprevalence in patients \> 30 years old.

Considering all of these data, it is possible to conclude that the seroconversion to AiV occurs during childhood or adolescence, which may be indicating a role of AiV as a causative agent of pediatric diarrhea (Sdiri-Loulizi *et al.*[@CR86]). Also, the high level of seroprevalence in adults showed in these surveys suggests a widespread exposure among human population to AiV.

Environmental Occurrence {#Sec13}
========================

Wastewater {#Sec14}
----------

AiV was identified in water in 2010 (Alcalá *et al.*[@CR3]). Since then, AiV was reported in high percentages in wastewater samples around the world (Table [3](#Tab3){ref-type="table"}). Current treatments applied in wastewater treatment plants (WWTPs), cannot guarantee a total removal of viral pathogens that are continuously discharged to the environment (da Silva *et al.*[@CR21]).Table 3Worldwide detection of AiV in wastewater.Country^a^Positive SamplesSample typeGenotypeCopies/LReferencesSouth Africa10/12Raw sewageNSNS^b^Onosi *et al.* ([@CR64])Tunisia10/125Raw sewageANSSdiri-Loulizi *et al.* ([@CR87])4/125Treated sewageANS51/102Raw sewageBNSIbrahim *et al.* ([@CR34])US24/24Raw sewageA,B1.2 × 10^4^--4.0 × 10^6^Kitajima *et al.* ([@CR47], [@CR48])24/24Treated sewageA,B2.0 × 10^3^--4.0 × 10^5^1/1Raw sewageNSNSCantalupo *et al.* ([@CR14])Iran7/10Raw sewageNS2.1 × 10^4^--1.9 × 10^6^Azhdar *et al.* ([@CR7])7/12Treated sewageNS4.2 × 10^3^--6.7 × 10^5^Japan137/207Raw sewageANSYamashita *et al.* ([@CR103])12/12Raw sewageA,BNSKitajima *et al.* ([@CR45])11/12Treated sewageANS12/12Raw sewageA1.4 × 10^5^--2.2 × 10^7^Kitajima *et al.* ([@CR46])11/12Treated sewageAUp to 1.8 × 10^4^11/12Raw sewageNSNSThongprachum *et al.* ([@CR91])Nepal1/1Raw sewageNSNSNg *et al.* ([@CR60])1/1Raw sewageBNSHaramoto and Kitajima ([@CR30])Thailand1/1Raw sewageNSNSNg *et al.* ([@CR60])France61/100Treated sewageNSUp to 10^3^Prevost *et al.* ([@CR76])Italy6/48Raw sewageBNSDi Martino *et al.* ([@CR23])Netherlands16/16Raw sewageA,BNSLodder *et al.* ([@CR54])Spain1/1Raw sewageNSNSCantalupo *et al.* ([@CR14])^a^Countries were ordered by continent and alphabetically within each continent.^b^NS, not specified.

In Japan AiV was detected in high percentages (from 66.2% to 100%) in raw sewage samples, with viral concentrations ranging from 1.4 × 10^5^ to 2.2 × 10^7^ copies/L (Yamashita *et al.*[@CR103]; Kitajima *et al.*[@CR45], [@CR46]). Samples of treated sewage also analyzed showed an AiV prevalence of 91.7% (Kitajima *et al.*[@CR45]). AiV detection in sewage showed no seasonality, being detected throughout the year (Thongprachum *et al.*[@CR91]). In other Asian countries, as Nepal, Thailand or Iran, AiV was also reported from untreated sewage samples (Ng *et al.*[@CR60]; Haramoto and Kitajima [@CR30]; Azhdar *et al.*[@CR7]). These studies supported the idea of use AiV as a human faecal pollution indicator, due its stability in wastewater and his lower removal percentages during wastewater treatments.

Other surveys detected AiV in Africa, America and Europe. In Africa, AiV was detected in Tunisia but at low prevalences. Thus, Sdiri-Loulizi *et al.* ([@CR87]) detected AiV in 10 out of 125 (8%) samples of influent water samples and 4 out of 125 (3.2%) treated sewage samples. On the other hand, Ibrahim *et al.* ([@CR34]) reported the virus in 51 out of 102 (50%) samples. Moreover, a recent study carried out in South Africa detected AiV in 10 out of 12 pooled sewage samples (Onosi *et al.*[@CR64]).

In USA, AiV was detected in a sample of untreated wastewater collected from Pennsylvania (Cantalupo *et al.*[@CR14]). Furthermore, another study carried out in two WWTPs of southern Arizona, detected AiV in all influent and effluent samples, with viral levels of 1.2 × 10^4^ to 4.0 × 10^6^ copies/L in influent samples and 2.0 × 10^3^--4.0 × 10^5^ copies/L in effluent samples (Kitajima *et al.*[@CR47]). A clear predominance of AiV B was revelaed in these positive samples (Kitajima *et al.*[@CR48]).

Finally, in Europe the percentages of detection vary. AiV was observed in sewage samples from France, the Netherlands and Spain with detection rates between 61 and 100% (Cantalupo *et al.*[@CR14]; Lodder *et al.*[@CR54]; Prevost *et al.*[@CR76]). However, other analysis of untreated influent sewage samples collected from four WWTPs in Italy detected AiV in only 12.5% of the samples (Di Martino *et al.*[@CR23]).

River Water and Groundwater {#Sec15}
---------------------------

Surface water is infiltrated via spreading basins into aquifers and wells but, due to their small size and their survival capacity, viral pathogens like AiV are not totally removed during this natural filtration (Weiss [@CR96]; Sharma and Amy [@CR89]). Therefore, river water and groundwater are also possible reservoirs for AiV (Table [4](#Tab4){ref-type="table"}).Table 4Worldwide detection of AiV in river, surface and ground waters.Country^a^Positive SamplesSample typeGenotypeCopies/LReferencesUS1/2Reclaimed waterNS^b^NSRosario *et al.* ([@CR83])7/12Ground water^b^NS1.0 × 10^2^--1.5 × 10^4^Betancourt *et al.* ([@CR108])Venezuela5/11River waterBNSAlcalá *et al.* ([@CR3])Iran15/28River waterNS3.4 × 10^2^--5.9 × 10^6^Azhdar *et al.* ([@CR7])Japan36/60River waterA + BNSKitajima *et al.* ([@CR45])29/29River waterNS8.6 × 10^2^--2.0 × 10^4^Hata *et al.* ([@CR31])20/52Surface waterNSUp to 10^4^Hata *et al.* ([@CR32])Nepal14/14River waterB1.2 × 10^6^--8.3 × 10^8^Haramoto and Kitajima ([@CR30])11/37Ground waterB5.6 × 10^4^--2.0 × 10^6^1/1Tap waterB10^9^France20/175River waterNSUp to 10^2^Prevost *et al.* ([@CR76])Netherlands12/14River waterA + BNSLodder *et al.* ([@CR54])^a^Countries were ordered by continent and alphabetically within each continent.^b^NS, not specified.

Although AiV had been previously detected in tap water in USA (Rosario *et al.*[@CR83]), the first study conducted to determine the occurrence and circulation of AiV in river water was carried out in Venezuela. In this study, AiV was detected in 5 out of 11 samples (45%) (Alcalá *et al.*[@CR3]). Other survey carried out in Japan for a longer period detected AiV in 36 out of 60 samples (60%), demonstrating a higher detection frequency for AiV than for other enteric virus, like NoV or SaV is the same set of river samples (Kitajima *et al.*[@CR45]). Hata *et al.* ([@CR31]), investigating the effects of rainfall events and water quality on viral occurrence, detected AiV in all the tested samples with relatively higher frequency of detection and concentration (ranging from 1.2 × 10^6^ to 8.3 × 10^8^ copies/L) than other enteric viruses. More recently, the same authors detected AiV in 20 out of 50 surface water samples in Japan (Hata *et al.*[@CR32]).

In Nepal, AiV was detected from river water, groundwater, tap water in a house supplied by tanker water, and from a sewage pipe (Haramoto and Kitajima, [@CR30]). In this study, differences in AiV detection were observed, and a high prevalence of AiV B was reported. The frequence of AiV detection was significantly higher in shallow dug wells, where AiV was found in 10 out of 22 samples (45%) than in shallow tube wells, in which AiV was found in 1 out of 15 samples (7%). In accordance with the study, this could be happened due to the vulnerable structure of dug wells, which are usually made of brick or stone, than tube wells. On the other hand, a recent study from Iran reported the detection of AiV in 50% of the river water samples analyzed (Azhdar *et al.*[@CR7]).

The first study for AiV detection in groundwater was performed in USA for the assessment of the occurrence and elimination of virus at a full-scale managed aquifer recharge system (Betancourt *et al.*[@CR108]). In this study, the concentration of AiV was up to 1.52 × 10^4^ copies/L. Recent environmental studies have demonstrated a high prevalence of AiV in different types of water samples, such as river and groundwater (Kitajima and Gerba [@CR44]).

There are also some surveys that reported AiV from river samples in Europe. In France, 20 out of 175 river water samples were positive for AiV with up to 10^2^ copies/L concentration levels (Prevost *et al.*[@CR76]). In the Netherlands, AiV was also detected in 12 out of 14 river water samples (Lodder *et al.*[@CR54]). The importance of that pathogen in this kind of samples is not well understood and more investigation will be needed to evaluate the real impact of AiV. Recently, Bonadonna *et al.* ([@CR11]) reported for the first time the presence and abundance of AiV in marine bathing waters in the Adriatic and Tyrrhenian Seas (Italy).

AIV in Shellfish {#Sec16}
----------------

Bivalve molluscs are associated with viral foodborne disease (Vossen [@CR94]) as they obtain their food filtering small particles suspended in water. Often in these processes, molluscs concentrate and retain pathogens including enteric viruses (Romalde *et al.*[@CR82]). These viruses are underestimated in molluscan safety controls that are based only on bacterial indicators, becoming this kind of food as a vector for enteric viruses transmission (Polo *et al.*[@CR74]).

From its first detection, AiV has been suggested as an important etiological agent of gastroenteritis especially in outbreaks associated with contaminated seafood (Table [5](#Tab5){ref-type="table"}) (Yamashita *et al.*[@CR98]). In Japan, a one-year study carried out between 2005 and 2006, reported AiV A from clam samples, with a prevalence of 73% (Hansman *et al.*[@CR29]).Table 5Worldwide detection of AiV in shellfish.Country^a^Positive SamplesSample typeGenotypeCopies/LReferenceSouth Africa8/12MusselsNS^b^NSOnosi *et al.* ([@CR64])Tunisia4/60Shellfish (NS)ANSSdiri-Loulizi *et al.* ([@CR87])Japan19/26ClamsANSHansman *et al.* ([@CR29])France6/66OystersNSNSLe Guyader *et al.* ([@CR50])Italy13/108MusselsNSUp to 10^2^Fusco *et al.* ([@CR26])3/170Mussels, Oysters, ClamsA,BNSTerio *et al.* ([@CR90])Spain15/249Mussels, Clams, CocklesNSNQ^c^--- 6.9 × 10^3^Rivadulla *et al.* ([@CR81])^a^Countries were ordered by continent and alphabetically within each continent.^b^NS, not specified.^c^NQ, non quantifiable (under the limit of quantification of the method).

Other studies reported AiV from shellfish samples worldwide. In Tunisia, Sdiri-Loulizi *et al.* ([@CR87]) reported an AiV prevalence of 4% in shellfish. Aditionally, the phylogenetic analysis revealed several clusters that occurred sequentially in time, pointing out some parallelism in the temporal shifts among environmental and human strains. On the other hand, Onosi *et al.* ([@CR64]) observed prevalence up to 66.6% in mussels from South Africa.

In France, other study detected AiV in oysters that were linked to a gastroenteritis outbreak and the AiV sequences obtained where similar to those from stool samples analyzed in parallel (Le Guyader *et al.*[@CR50]). More recently, AiV has been detected from shellfish in Spain and Italy (Fusco *et al.*[@CR26]; Rivadulla *et al.*[@CR81]; Terio *et al.*[@CR90]), with prevalence ranging from 1.7 to 12%.

Zoonotic Potential of Animal *Kobuvirus* {#Sec17}
========================================

As mentioned above, non-human Aichivirus have been described from different animal species, including some types of *Aichivirus A*, and those included in species *Aichivirus B* to *Aichivirus F*. All of them had a standard picornavirus genome organization and sequence homology to human *Aichivirus A* (Otomaru *et al.*[@CR66]), with the exception of *Aichivirus C*, which possesses a type IV IRES instead of the typical type V IRES present in the other *Kobuvirus* species.

Animal *Kobuvirus* can be transmitted directly by physical contact, or indirectly through water and food by the faecal-oral route (Reuter *et al.*[@CR79]). Using Bayesian phylogenetic methods, evidences has been obtained for transmission between different host taxa along *Kobuvirus* evolution, including host jumps from artiodactyla (sheep) to carnivora (ferret), from bats to rabbits, or from carnivora to birds and humans (Lu *et al.*[@CR55]). In addition, evidences of zoonotic infection or interspecies transmission of bovine kouvirus to pig was documented (Kharim *et al.*[@CR41]), suggesting that close contact among different animal species may increase the possibilities of interspecies transmission. However, further investigations over larger geographical scales and in other host species will be needed to clarify the evolutionary connections and host jumps.

Concluding Remarks {#Sec18}
==================

Since the first documented outbreak associated with food, it has become evident the importance of viruses as pathogens that cause alimentary illness. Also, the ineffectiveness of the current mechanisms of microbiological control in seafood, from a virological point of view, as well as the current vulnerability of our global food market are key factors in the appearance of outbreaks (Polo *et al.*[@CR73]).

Our awareness of the risk associated to AiV as an etiological agent of gastroenteritis is increasing in the last years. As for other viruses, AiV stability allows its persistence stay in the environment for long periods, as well as its transmission to humans by ingestion of contaminated water and molluscs.

Although until now AiV is responsible for a low percentage of reported gastroenteritis outbreaks, the high seroprevalence shown by human populations indicates an evident role as an enteric agent. The low percentage of AiV detection could be explained by the lack of a routinary method for AiV screening, although the fact that the pathogen may be more associated to asymptomatic infections could not be ruled out. However, the methodological advances in molecular biology lead to the development of new technologies that improve the detection of these pathogens. Furthermore, these new methodologies are also lighting the investigation to clarify the transmission routes of AiV infection, solving the limitations of the classical detection methods.

In summary, further studies are needed in order to know the full spectrum of clinical symptoms of AiV, as well as the burden of AiV disease in humans not only to improve our understanding of their clinical significance but also to determine the necessity of preventive measures, including specific vaccine development.
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